Current and Emerging Immunotherapies for Recurrent Cervical Cancer

Abstract: Approximately 4290 women in the United States and 311,000 women worldwide died of cervical cancer in 2021. The management of advanced, recurrent, and/or metastatic cervical […]

Stereotactic Body Radiation Therapy and Immunotherapy

  Abstract: Immunotherapy has revolutionized the treatment of various types of cancers in recent years. Since the US Food and Drug Administration approval of the anti–cytotoxic […]

Managing Adverse Effects of Immunotherapy

  Abstract: Remarkable efficacy has been achieved in a variety of cancer types by targeting immune checkpoints. The cytotoxic T-lymphocyte–associated antigen 4 inhibitor ipilimumab, the programmed […]